SC
WST icon

Savant Capital’s West Pharmaceutical WST Stock Holding History

Savant Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Buy
+870
New +$216K ﹤0.01% 1359
2025
Q1 		– Sell
-1,003
Closed -$329K – 1447
2024
Q4 		$329K Buy
1,003
+131
+15% +$41.2K ﹤0.01% 1063
2024
Q3 		$262K Buy
872
+75
+9% +$23K ﹤0.01% 1154
2024
Q2 		$263K Buy
797
+99
+14% +$35K ﹤0.01% 1032
2024
Q1 		$276K Sell
698
-92
-12% -$34K ﹤0.01% 925
2023
Q4 		$278K Sell
790
-100
-11% -$35.4K ﹤0.01% 725
2023
Q3 		$334K Buy
890
+56
+7% +$21.7K 0.01% 624
2023
Q2 		$319K Buy
834
+167
+25% +$59.7K 0.01% 634
2023
Q1 		$231K Buy
+667
New +$195K ﹤0.01% 650
2022
Q3 		– Sell
-810
Closed -$245K – 582
2022
Q2 		$245K Buy
+810
New +$264K 0.01% 476

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return